Sighthound Owners!
Pass this on in case anyone would like to participate...
The Pharmacogenomics Research Lab in the Washington State University College of Veterinary Medicine is currently conducting a study with the purpose of identifying genetic predispositions to adverse drug reactions. The long term goal of this study is to develop genetic tests to identify dogs that may be at increased risk of experiencing an adverse reaction to specific drugs. These gene differences occur more frequently in specific breeds of dogs. We are looking to collect DNA samples from the following dog breeds:
Greyhound*
Azawakh
Borzoi (Russian Wolfhound)
Chart Polski (Polish Greyhound)
Galgo Español
Afghan Hound
Hortaya Borzaya
Irish Wolfhound
Italian Greyhound
Magyar agár (Hungarian Greyhound)
Saluki
Scottish Deerhound
Silken Windhound
Sloughi
Whippet
Long-haired whippet
Appalachian Greyhound
Basenji
Canary Islands Hound Podenco Canario
Cirneco dell'Etna
Ibizan Hound (Podenco Ibicenco)
Pharaoh Hound (Kelb tal-fenek)
Portuguese Podengo
Rhodesian Ridgeback
Peruvian Inca Orchid
Thai Ridgeback
Soft-coated Wheaten Terrier
The process is simple. DNA will be collected by swabbing the inside of your dog’s mouth cheek with a soft bristle brush. The brush will be taken to the lab, DNA extracted, analyzed, and stored for future study. There will be no cost to you. At the end of the study we will email you the results of the analysis for your dog/s.
If you have a dog that meets one of the above breed specifications and would like to participate in this study, or need more information, please contact Hannah Bigelow (hbigelow@vetmed.wsu.edu).
*Although we want DNA from all of the breeds listed above, we are most interested in sampling from Greyhounds.
Hannah Bigelow
|
Jean Dodds Seminar at Albany Obedience Club
November 8 & 9, 2014
WHAT YOU NEED TO KNOW ABOUT YOUR DOG'S HEALTH BUT FORGOT TO ASK
“Spend a weekend learning the most up to date information about the canine immune system, vaccination protocols, titers, the rabies challenge and hypothyroidism. Dr. Jean Dodds needs no introduction. She the founder of Hemopet based in California. Dr. Dodd's new book: ‘Functional Foods that Heal your Dog: the Power of Nutrigenomics.’ 2014. DogWise Publishing, Wenatchee, WA will be released this year.”
Saturday 9 to 4:30 pm. Sunday 9 to 4:30 pm
Beverages and light snacks will be included.
Albany Obedience Club
535 Wemple Rd., Glenmont NY 12077
AOC members: two days $130 _ one day $70 _
Non-members: two days $170 _ one day $90 _
Registration closes November 1st
Flyer and Registration Form
from Patty Ewing
Something to be aware of:
Tramadol will become a schedule IV controlled substance on August 18th. That means that a veterinarian will need a DEA license to prescribe it and will have to follow DEA regulations and meet recordkeeping requirements when prescribing this drug.
The ruling was in part based on the fact that Tramadol is an opiate which means it is capable of triggering addictions similar to that of morphine, though it is recognized that the potential for abuse is low and physical dependence is limited (thus the designation as schedule IV).
http://atwork.avma.org/2014/07/02/tramadol-to-become-schedule-iv-controlled-substance/#comments
More:
Tramadol has been classified as a controlled substance in Oklahoma since Oct 2012. Okies got a head start! It is not uncommon for some states to have stricter regulations than federal regulations. There are other states that have already classified Tramadol as a controlled substance prior to this new federal ruling which will apply to ALL stares. They recognized the abuse issues sooner....employee theft or owners taking Tramadol prescribed for their dog.
Phenobarb has been classified as a controlled substance at the federal level for decades, so that is not new. What may have happened is that your state's pharmacy board may have recently changed prescribing regulations that limit refills and only allow 1 month of phenobarb to be prescribed at a time.
Here is a link to the AVMA website with more information: http://atwork.avma.org/.../tramadol-to-become.../...
Additional information: http://www.gpo.gov/.../pkg/FR-2014-07-02/pdf/2014-15548.pdf
|